[Drug administration. Notes from the Adverse Drug Reaction Board. Halogenated anasthetics can develop carbon monoxide in reaction with dry absorbent calcium].
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000701:Analgesics, Opioid / Q000009:adverse effects; D018685:Anesthetics, Inhalation / Q000009:adverse effects* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002248:Carbon Monoxide / Q000138:chemical synthesis*; D005260:Female; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000009:adverse effects* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D019966:Substance-Related Disorders; D014147:Tramadol / Q000009:adverse effects
D000701:Analgesics, Opioid; D018685:Anesthetics, Inhalation; D006846:Hydrocarbons, Halogenated; D014147:Tramadol; D002248:Carbon Monoxide; D002118:Calcium
Laegemiddelstyrelsen. Notitser fra Bivirkningsnaevnet. Halogenerede anaestetika kan udvikle kulilte i forbindelse med udtørret absorberkalk.